Track Medtech Start-ups

Learn More

Keynote

Medtech 3.0 & Creating Unicorns

Scott will deliver a Keynote address on February 18th and share his vision for the future of medtech and why now is the time to build, not backpedal.  He'll share insights and experiences from the past and provide his unique perspective on the opportunities ahead.  His session will address thinking big during the COVID era and the digital transformation to improve access to care, lower cost and improve patient outcomes.

Huennekens has more than 25 years of experience in the medical device industry, specializing in clinical advancement through innovative R&D and technology-based initiatives. He currently serves as Executive Chairman of the Board for Acutus Medical (IPO in 2020).  He has held a number of executive leadership roles within the healthcare industry, accelerating the next generation of digital surgery for Verb Surgical and leading Volcano Corporation, an image guided therapy device company, to its IPO in 2006. He holds an MBA from Harvard University and a BS in Business Administration from the University of Southern California. Huennekens currently sits on the boards of public companies Viewray and NuVasive.

Scott Huennekens

Scott Huennekens

Executive Chairman, Acutus Medical

Keynote

Fireside Chat

Conversation With A Medtech Visionary

In this conversation, we'll tap into the experiences, wisdom and projections of medtech mogul, Paul LaViolette.  We'll learn what Paul and his partners are up to with their new Medtech Convergence Fund and we'll have some fun talking about stories from the past and opportunities of the future.  

Paul LaViolette

Paul LaViolette

Managing Partner, SV Health Investors, Medtech Convergence Fund

Fireside Chat

Scott Pantel

Scott Pantel

CEO, Life Science Intelligence

Moderator

Investor Panel

Medtech Venture Capital in 2021: What Investments Will We See?

In this panel we'll talk to active VCs about the types of deals they are in now and we'll find out what new deals they are looking for in 2021 and beyond. 

The panel will be moderated by Lisa Carmel.  Lisa is an industry insider, VP of Strategy with Ximedica,  and she advises top medtech startups and accelerators, while also serving on the board of various organizations.

Greg Madden

Greg Madden

Partner, SV Health Investors

Panelist

Amy Belt Raimundo

Amy Belt Raimundo

Managing Director, Kaiser Permanent Ventures

Panelist

Geoff Pardo

Geoff Pardo

Partner, Gilde Healthcare Partners

Panelist

Jon Root

Jon Root

General Partner, US Venture Partners

Panelist

Terri Burke

Terri Burke

Venture Partner, Epidarex Capital

Panelist

Dennis McWilliams

Dennis McWilliams

Venture Partner, Sante Ventures

Panelist

Tak Cheung

Tak Cheung

Principal, New Enterprise Associates

Panelist

Lisa Carmel

Lisa Carmel

Vice President Strategy, Ximedica

Moderator

Oliver Keown

Oliver Keown

Intuitive Ventures, Intuitive Surgical

Panelist

Strategic Panel

Medtech M&A Post COVID

In this panel we'll look at medtech M&A coming out of COVID.  What kind of deals are strategics looking for?  How has their strategy changed (or not changed) as a result of what we've learned?  What deals will see in 2021 and beyond?

The panel will be moderated by industry insider and Alira Health Senior Partner & VP, David Uffer.

Additional panelists from major strategics to be announced soon.

Gwen Watanabe

Gwen Watanabe

VP of Global Corporate Development, Strategy and Strategic Relationships, Teleflex

Panelist

David Uffer

David Uffer

Senior Partner & VP, Alira Health

Moderator

Strategic Panel

How (& When) to Engage Corporates

This panel will be moderated by industry veteran and ex-J&J executive Nicholas Pachuda.  Nick's panelists will include strategics and corporate investors with decades of experience working with entrepreneurs from seed to late stage.  They'll share insights, success stories (plus a few war stories), and provide a strategic partnering roadmap for medical technology innovators and their investors.

Additional Panelists Announced Soon.

Nicholas Mourlas

Nicholas Mourlas

Sr. Director New Ventures, Johnson & Johnson Innovation

Panelist

Melinda Richter

Melinda Richter

Global Head, Johnson & Johnson Innovation JLABS

Panelist

Nicholas Pachuda

Nicholas Pachuda

Innovation & New Ventures, Pure Medtech Advisors

Moderator

More Investor, Strategic & Thought-Leader Panels Coming

Check back regularly as we are building content for our 2021 program now.  We will deliver insightful and thought-provoking panel sessions with investors, strategics and innovators that are on the forefront of the medtech ecosystem.

Panelist TBA

Panelist TBA

Panelist TBA

Panelist TBA

Our Clients